Shares of Bio-Techne Corp. TECH inched 0.40% higher to $73.03 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.10% to ...

Shares of Bio-Techne Corp. TECH slumped 0.59% to $72.74 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.73% to 5,974. ...

MINNEAPOLIS - Bio-Techne (NASDAQ:TECH) Corporation (NASDAQ: TECH), a provider of automated platforms for biotherapeutic characterization with a market capitalization of $11.35 billion, announced today ...

(RTTNews) - Bio-Techne Corporation (TECH), a provider of life science reagents, instruments and services, Thursday announced a co-marketing and co-promotion agreement with Waters Corporation to ...

Bio-Techne (TECH) announced a co-marketing and co-promotion agreement with Waters Corporation aimed at expanding the reach of advanced biotherapeutic characterization and development processes.

MINNEAPOLIS, Dec. 19, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a leader in automated platforms for biotherapeutic characterization, today announced a co-marketing and co ...

5] Click on the 'Search' button. Your Hamps Bio IPO allotment status will become available on your computer monitor or your cell phone screen.

By 9:45, they began asking themselves a very hard question about the unauthorized biography, titled Chrystia: From Peace River to Parliament Hill. Could they push up its publishing date?

Bio-Techne Corp. TECH has launched a highly sensitive ESR1 mutation monitoring assay through its Asuragen brand. ESR1 gene mutations are known to be linked to hormone receptor-positive (HR+ ...